MENUMENU
- Industries
- AI Solutions
AI Solutions
- Products
Products
- Services
- Agent5i
- Thought Leadership
THOUGHT LEADERSHIP
- About Us
- Contact Us
Evolving with AI
Drive business impact at scale through smarter decisions and agentic actions using AI and human intelligence. Accelerate innovation, commercialization, and Patient outcomes.
Talk to an ExpertAccelerate clinical, regulatory, and safety decision-making with AI-powered analysis of clinical evidence, trial activity, treatment landscapes, and emerging data. C5i combines advanced analytics, therapeutic expertise, and agentic AI to uncover opportunities, assess risks, streamline reporting, strengthen pharmacovigilance, and guide confident decisions across the product lifecycle.
Accelerate early-stage asset decisions with AI-powered scientific and competitive intelligence. Use agentic AI to continuously analyze clinical data, therapy landscapes, research activity, and market signals to identify promising opportunities, assess asset potential faster, and support evidence-based portfolio and investment decisions.
Streamline regulatory and scientific reporting with AI-powered content automation and intelligent workflows. Use AI to accelerate document authoring, evidence synthesis, data validation, and compliance reviews while improving accuracy, reducing manual effort, and enabling faster submission-ready scientific and regulatory communications.
Strengthen pharmacovigilance and safety intelligence with AI-powered adverse event reporting and signal detection. Use agentic AI to continuously monitor, extract, classify, and analyze safety signals from scientific literature, regulatory updates, competitor disclosures, and other external sources to accelerate signal assessment, improve compliance, and enable earlier identification of emerging safety risks and market implications.
Turn complexity into clarity with AI-driven strategic insights. Empower life sciences teams to anticipate competitor moves, decode disease and market dynamics, and convert disparate data into timely, actionable intelligence that sharpens strategy, guides investment decisions, and creates long-term competitive advantage.
Monitor evolving therapy areas, markets, competitors, and innovations in real time. Apply AI-driven intelligence to identify opportunities, anticipate threats, and inform product, launch, and lifecycle commercialization strategies.
Leverage AI and deep domain expertise to deliver timely, actionable insights through C5i’s Agentic AI platform for market and competitor insights. Monitor competitors in real time and apply intelligent automation to stay ahead of market shifts, identify opportunities, and make confident, well-informed decisions.
Gain forward-looking insights through Primary Competitive Intelligence (CI) that secondary research alone cannot provide. Gather actionable intelligence on all stages of the product lifecycle – from competitors’ clinical development strategies, through to regulatory approval and launch timelines, commercialization strategies, and generic and biosimilar entries – and proactively counter competitive threats.
Transform medical and scientific conferences into intelligence sources. These vital hubs of biopharmaceutical activity drive announcements, industry dialogue, and KOL engagement. C5i amplifies their value through AI-driven pre-conference planning, on-site support, and post-conference analysis.
Leverage an integrated AI-driven approach to competitor monitoring, horizon scanning, and market analysis, delivering actionable, data-driven insights. From discovery to commercialization, C5i’s Strategic Intelligence and Opportunity Assessment solution helps you identify opportunities, prioritize assets, and guide Business Development & Licensing (BD&L) strategy for lasting competitive advantage.
Synthesize clinical evidence, real-world data, and market and behavioral insights using advanced analytics and generative AI. Uncover actionable, cross-validated insights and deliver compelling medical and commercial narratives that drive confident, evidence-based strategic decisions.
Unify consumer and market signals across the commercialization value chain. Synthesize omnichannel data to understand healthcare practitioner (HCP), opinion leader (KOL), and patient behavior and perspectives. Personalize engagement, optimize campaigns and liaison (MSL) deployment, and improve patient outcomes and brand performance.
Accelerate life sciences market and clinical research with end-to-end AI-enabled market research operations and integrated data. Reduce cycle times, scale global studies efficiently, and empower teams to deliver faster, higher-quality insights with improved ROI.
Test customer experience hypotheses rapidly using privacy-safe synthetic audiences. Simulate real-world HCP, patient, and payer attitudes, validate treatment, messaging, and trial concepts early, and accelerate decision-making without dependence on time-consuming primary research. Go to market faster.
Capture real-time HCP, patient, and caregiver sentiment across digital channels. Analyze unstructured conversations at scale to identify emerging disease, treatment, and safety-related trends, unmet needs, and risks impacting brand and reputation.
Monitor evolving therapy areas, markets, competitors, and innovations in real time. Apply AI-driven intelligence to identify opportunities, anticipate threats, and inform product, launch, and lifecycle commercialization strategies.
Synthesize clinical evidence, real-world data, and market and behavioral insights using advanced analytics and generative AI. Uncover actionable, cross-validated insights and deliver compelling medical and commercial narratives that drive confident, evidence-based strategic decisions.
By synthesizing insights from digital channels, medical liaison (MSL) interactions, marketing campaigns, and medical congress activities, we provide a 360-degree view of HCP, KOL, and patient behaviors. C5i’s solutions empower your teams to deliver the right message through the ideal channel at the optimal time, driving brand growth, scientific trust, and superior patient outcomes.
Deliver integrated insights that enable commercial teams to orchestrate personalized engagement across all customer touchpoints. By synthesizing data from marketing campaigns, digital channels, promotional activities, and customer interactions, we provide a unified view of HCP and patient preferences and behaviors. C5i’s AI and analytics solutions optimize marketing effectiveness, campaign performance, audience segmentation, and channel mix while enabling the right message through the right channel at the right time, driving brand awareness, market share growth, and ROI.
Empower medical affairs teams with integrated insights that enhance scientific engagement and evidence dissemination. By consolidating data from MSL interactions, congress activities, advisory boards, and digital platforms, we create a comprehensive view of KOL and HCP scientific needs. C5i’s AI and analytics solutions optimize MSL deployment, coordinate scientific exchange strategies, and personalize medical content delivery while maintaining compliance, supporting evidence-based treatment decisions and improved patient outcomes.
Deliver integrated operations intelligence that drives efficiency, productivity, and cost optimization across the life sciences value chain. C5i’s AI and analytics solutions empower organizations to optimize operations within R&D, manufacturing, supply chain, quality, and enterprise functions by identifying bottlenecks, improving resource allocation, and streamlining workflows. We enable organizations to enhance portfolio management, improve lab and production efficiency, optimize capacity planning, monitor vendor performance, and reduce operational costs. Through advanced AI and predictive analytics, we transform operational data into strategic intelligence that accelerates decision-making, improves process excellence, and builds resilient operations capable of adapting to market dynamics and regulatory requirements.
Turn workforce data into action with agentic AI. Predict talent needs, optimize performance, elevate employee experience, and enable governed people decisions that improve productivity, retention, and measurable business outcomes at scale.
Activate agentic workforce intelligence to forecast capacity, optimize skills deployment, and automate planning decisions. Transform people analytics into decision science that drives productivity, reduces attrition, and aligns talent with business outcomes.
Elevate employee experience with agentic AI using e-Sat and social sensing models to detect sentiment, predict retention risk, personalize interventions, and continuously improve engagement. Reduce turnover while building resilient, high-performing workplaces.
Accelerate performance with agentic analytics that connect goals, skills, and outcomes. Deliver real-time insights, objective evaluations, and automated recommendations to boost productivity, close capability gaps, and enable smarter people decisions at scale.
Unlock enterprise-grade AI for Life Sciences. Unify data, analytics, and AI to drive faster insights, governed automation, and scalable impact across R&D, medical, and commercial operations. Accelerate innovation, improve decisions, and deliver measurable outcomes at scale.
Deploy governed Agentic AI and Generative AI to automate workflows, augment decisions, and accelerate enterprise productivity. Leverage domain-aware agents and secure GenAI to execute critical processes, personalize experiences, and deliver audit-ready, human-in-the-loop automation across revenue, customer, and operational operations.
Create competitive advantage with Applied AI. Scale enterprise AI to unlock dark data, modernize hybrid infrastructure, operationalize models with MLOps, and drive measurable business impact.
Modernize and transform your data foundation. Optimize costs, improve data quality and governance, enable 360-degree views, and power intelligent operations with scalable, cloud-ready data engineering.
Scale data science to production. Unify the ML lifecycle with MLOps to train, deploy, monitor, and govern models reliably using automated, repeatable, enterprise-ready pipelines.
Elevate data visualization and BI. Optimize costs, modernize dashboards, and drive insight adoption through AI-powered analytics, visual storytelling, and engaging, design-led experiences.
Power AI with scalable cloud infrastructure. Design use-case-driven environments, deploy AI accelerators, optimize storage and compute, and ensure reliable, cost-effective AI and ML operations.
Operationalize AI at scale with X-Ops. Unify DevOps, DataOps, MLOps, and LLMOps to deploy, govern, and optimize AI systems faster, responsibly, and with sustained business impact.
Strengthen decision-making with C5i’s Decision Intelligence Advisory. Apply data, analytics, and AI to democratize insights, elevate leadership decisions, accelerate problem-solving, and drive measurable business impact.
Accelerate clinical, regulatory, and safety decision-making with AI-powered analysis of clinical evidence, trial activity, treatment landscapes, and emerging data. C5i combines advanced analytics, therapeutic expertise, and agentic AI to uncover opportunities, assess risks, streamline reporting, strengthen pharmacovigilance, and guide confident decisions across the product lifecycle.
Accelerate early-stage asset decisions with AI-powered scientific and competitive intelligence. Use agentic AI to continuously analyze clinical data, therapy landscapes, research activity, and market signals to identify promising opportunities, assess asset potential faster, and support evidence-based portfolio and investment decisions.
Streamline regulatory and scientific reporting with AI-powered content automation and intelligent workflows. Use AI to accelerate document authoring, evidence synthesis, data validation, and compliance reviews while improving accuracy, reducing manual effort, and enabling faster submission-ready scientific and regulatory communications.
Strengthen pharmacovigilance and safety intelligence with AI-powered adverse event reporting and signal detection. Use agentic AI to continuously monitor, extract, classify, and analyze safety signals from scientific literature, regulatory updates, competitor disclosures, and other external sources to accelerate signal assessment, improve compliance, and enable earlier identification of emerging safety risks and market implications.
Turn complexity into clarity with AI-driven strategic insights. Empower life sciences teams to anticipate competitor moves, decode disease and market dynamics, and convert disparate data into timely, actionable intelligence that sharpens strategy, guides investment decisions, and creates long-term competitive advantage.
Monitor evolving therapy areas, markets, competitors, and innovations in real time. Apply AI-driven intelligence to identify opportunities, anticipate threats, and inform product, launch, and lifecycle commercialization strategies.
Leverage AI and deep domain expertise to deliver timely, actionable insights through C5i’s Agentic AI platform for market and competitor insights. Monitor competitors in real time and apply intelligent automation to stay ahead of market shifts, identify opportunities, and make confident, well-informed decisions.
Gain forward-looking insights through Primary Competitive Intelligence (CI) that secondary research alone cannot provide. Gather actionable intelligence on all stages of the product lifecycle – from competitors’ clinical development strategies, through to regulatory approval and launch timelines, commercialization strategies, and generic and biosimilar entries – and proactively counter competitive threats.
Transform medical and scientific conferences into intelligence sources. These vital hubs of biopharmaceutical activity drive announcements, industry dialogue, and KOL engagement. C5i amplifies their value through AI-driven pre-conference planning, on-site support, and post-conference analysis.
Leverage an integrated AI-driven approach to competitor monitoring, horizon scanning, and market analysis, delivering actionable, data-driven insights. From discovery to commercialization, C5i’s Strategic Intelligence and Opportunity Assessment solution helps you identify opportunities, prioritize assets, and guide Business Development & Licensing (BD&L) strategy for lasting competitive advantage.
Synthesize clinical evidence, real-world data, and market and behavioral insights using advanced analytics and generative AI. Uncover actionable, cross-validated insights and deliver compelling medical and commercial narratives that drive confident, evidence-based strategic decisions.
Unify consumer and market signals across the commercialization value chain. Synthesize omnichannel data to understand healthcare practitioner (HCP), opinion leader (KOL), and patient behavior and perspectives. Personalize engagement, optimize campaigns and liaison (MSL) deployment, and improve patient outcomes and brand performance.
Accelerate life sciences market and clinical research with end-to-end AI-enabled market research operations and integrated data. Reduce cycle times, scale global studies efficiently, and empower teams to deliver faster, higher-quality insights with improved ROI.
Test customer experience hypotheses rapidly using privacy-safe synthetic audiences. Simulate real-world HCP, patient, and payer attitudes, validate treatment, messaging, and trial concepts early, and accelerate decision-making without dependence on time-consuming primary research. Go to market faster.
Capture real-time HCP, patient, and caregiver sentiment across digital channels. Analyze unstructured conversations at scale to identify emerging disease, treatment, and safety-related trends, unmet needs, and risks impacting brand and reputation.
Monitor evolving therapy areas, markets, competitors, and innovations in real time. Apply AI-driven intelligence to identify opportunities, anticipate threats, and inform product, launch, and lifecycle commercialization strategies.
Synthesize clinical evidence, real-world data, and market and behavioral insights using advanced analytics and generative AI. Uncover actionable, cross-validated insights and deliver compelling medical and commercial narratives that drive confident, evidence-based strategic decisions.
By synthesizing insights from digital channels, medical liaison (MSL) interactions, marketing campaigns, and medical congress activities, we provide a 360-degree view of HCP, KOL, and patient behaviors. C5i’s solutions empower your teams to deliver the right message through the ideal channel at the optimal time, driving brand growth, scientific trust, and superior patient outcomes.
Deliver integrated insights that enable commercial teams to orchestrate personalized engagement across all customer touchpoints. By synthesizing data from marketing campaigns, digital channels, promotional activities, and customer interactions, we provide a unified view of HCP and patient preferences and behaviors. C5i’s AI and analytics solutions optimize marketing effectiveness, campaign performance, audience segmentation, and channel mix while enabling the right message through the right channel at the right time, driving brand awareness, market share growth, and ROI.
Empower medical affairs teams with integrated insights that enhance scientific engagement and evidence dissemination. By consolidating data from MSL interactions, congress activities, advisory boards, and digital platforms, we create a comprehensive view of KOL and HCP scientific needs. C5i’s AI and analytics solutions optimize MSL deployment, coordinate scientific exchange strategies, and personalize medical content delivery while maintaining compliance, supporting evidence-based treatment decisions and improved patient outcomes.
Deliver integrated operations intelligence that drives efficiency, productivity, and cost optimization across the life sciences value chain. C5i’s AI and analytics solutions empower organizations to optimize operations within R&D, manufacturing, supply chain, quality, and enterprise functions by identifying bottlenecks, improving resource allocation, and streamlining workflows. We enable organizations to enhance portfolio management, improve lab and production efficiency, optimize capacity planning, monitor vendor performance, and reduce operational costs. Through advanced AI and predictive analytics, we transform operational data into strategic intelligence that accelerates decision-making, improves process excellence, and builds resilient operations capable of adapting to market dynamics and regulatory requirements.
Turn workforce data into action with agentic AI. Predict talent needs, optimize performance, elevate employee experience, and enable governed people decisions that improve productivity, retention, and measurable business outcomes at scale.
Activate agentic workforce intelligence to forecast capacity, optimize skills deployment, and automate planning decisions. Transform people analytics into decision science that drives productivity, reduces attrition, and aligns talent with business outcomes.
Elevate employee experience with agentic AI using e-Sat and social sensing models to detect sentiment, predict retention risk, personalize interventions, and continuously improve engagement. Reduce turnover while building resilient, high-performing workplaces.
Accelerate performance with agentic analytics that connect goals, skills, and outcomes. Deliver real-time insights, objective evaluations, and automated recommendations to boost productivity, close capability gaps, and enable smarter people decisions at scale.
Unlock enterprise-grade AI for Life Sciences. Unify data, analytics, and AI to drive faster insights, governed automation, and scalable impact across R&D, medical, and commercial operations. Accelerate innovation, improve decisions, and deliver measurable outcomes at scale.
Deploy governed Agentic AI and Generative AI to automate workflows, augment decisions, and accelerate enterprise productivity. Leverage domain-aware agents and secure GenAI to execute critical processes, personalize experiences, and deliver audit-ready, human-in-the-loop automation across revenue, customer, and operational operations.
Create competitive advantage with Applied AI. Scale enterprise AI to unlock dark data, modernize hybrid infrastructure, operationalize models with MLOps, and drive measurable business impact.
Modernize and transform your data foundation. Optimize costs, improve data quality and governance, enable 360-degree views, and power intelligent operations with scalable, cloud-ready data engineering.
Scale data science to production. Unify the ML lifecycle with MLOps to train, deploy, monitor, and govern models reliably using automated, repeatable, enterprise-ready pipelines.
Elevate data visualization and BI. Optimize costs, modernize dashboards, and drive insight adoption through AI-powered analytics, visual storytelling, and engaging, design-led experiences.
Power AI with scalable cloud infrastructure. Design use-case-driven environments, deploy AI accelerators, optimize storage and compute, and ensure reliable, cost-effective AI and ML operations.
Operationalize AI at scale with X-Ops. Unify DevOps, DataOps, MLOps, and LLMOps to deploy, govern, and optimize AI systems faster, responsibly, and with sustained business impact.
Strengthen decision-making with C5i’s Decision Intelligence Advisory. Apply data, analytics, and AI to democratize insights, elevate leadership decisions, accelerate problem-solving, and drive measurable business impact.
Accelerated path from unmet medical needs to positive patient outcomes
Market-leading commercialization outcomes
Elevated customer experiences by maximizing HCP loyalty and patient adherence
Improved operational efficiency by transforming fragmented data into a high-velocity decision engine
Manual CI workflows consumed significant analyst time, limiting productivity and scalability. Limited human bandwidth restricted real-time, comprehensive coverage across competitors, markets, and geographies. These manual processes also led to data inconsistencies, missed signals, and slower decision-making. As a result, traditional CI lacked the agility and personalization needed for effective strategic response.
A global pharmaceutical organization faced significant challenges in deriving unified insights from its fragmented omnichannel marketing ecosystem. Its marketing performance data was dispersed across multiple internal and external sources, leading to inconsistencies, quality issues, and limited data observability.
A leading global Automotive OEM wanted to identify cost reduction opportunities for Parcel shipments to customers. It was challenging to reduce parcel freight expenses because there was no systematic way to analyze the available data.
The client’s goal was to build a high-performance, scalable solution that could process vast amounts of campaign data, enable real-time insights, and enhance user experience.
The client sought a scalable, cloud-based solution to integrate, harmonize, and analyze data across multiple touchpoints to gain actionable insights into their value chain and improve both customer and operational outcomes.
In an era of increasing customer interactions and operational complexity, our client wanted to convert their growing volume of audio data into actionable insights. The goal was to improve their customer experience, optimize agent performance, and drive operational excellence by leveraging AI technologies.
The client was looking for an omnichannel marketing analytics solution to get granular insights into what parameters affected campaign performance and recommendations to optimize costs and improve outcomes.
Course5 was engaged to support the client in automating and streamlining the information feed system, and presenting it intuitively to optimize clinical workflows. The requirement was to use advanced analytics methodology and technology to enable real-time candidate matching.
The client had a significant amount of patient data from clinical studies, which came either from in-house studies or studies of acquired companies. The overall dataset exhibited heterogeneity, encompassing a diverse array of features such as demographic details, vital statistics, treatment history, medication records, lab results, etc. The process of retrieving specific information from this […]
Marketing Operations group at this client had rolled out a platform for Centralized Marketing Activities that captures marketing operations activities, associated plans and allows for visibility and tracking and ongoing optimization. Their process of preparing and analyzing this data was manual and adhoc in nature and required a consistent and standardized approach to report KPIs […]
The client had recently launched a drug in the Chronic Kidney Disease (CKD) with Type 2 Diabetes (T2D) market. The uptake was good, yet below expectations. They wanted to understand the current treatment patterns and identify targets that are highly likely to see a patient with the indication of interest.
The client had a suite of ML models created by internal and external partners. Most of these were propensity models designed for Next Best Action (NBA) to optimize recommendations for HCP Engagement across ONC and CV therapy areas. They wanted to develop an in-house end-to-end MLOps framework to streamline the deployment process and ensure smooth […]
Helped the client benchmark their own field resources against key competitors, enabling them to make informed decisions on field force structure. Enabled the client to perform gap analysis in their promotional strategy and devise plans to boost their market share-of-voice
Healthcare data is usually complex and not very easy to consume. Our client, a pharma consulting company, wanted to be able to engage with their clients working on different domains of pharma research and handling multiple types of projects, ad wanted to help the team to essay their story in a visually impactful manner.
The objective of the study was to understand how much consumers already know about Gene Therapy (GT) for Hemophilia in order to inform the messaging and positioning strategy for their new drug in the EU5 markets (France, Germany, Italy, Spain, United Kingdom).
The objective of the study was to understand the themes of conversations on early-stage relapse of Multiple Myeloma by patients and medical professionals.
To design and deliver a customized CI program for continuous monitoring and reporting key competitor activities for both marketed products and pipeline molecules.
To provide CI support through continuous monitoring and reporting of key competitor events in biosimilars
Provide end-to-end conference coverage including primary and secondary intelligence gathering based on KITs and KIQs
Helped senior executives within the client company to easily view and assimilate high-level insights at the indication/competitor/industry-levels.
To understand the organizational and functional structure of patient advocacy programs (PAPs) of 5 major competitors in the oncology space
To estimate the sales force and medical field force size (FTEs), structure and organization of identified competitor portfolio
To design and deliver a customized CI program for continuous monitoring and reporting key competitor activities for both marketed products and pipeline molecules.
Provide end-to-end conference coverage including primary and secondary intelligence gathering based on KITs and KIQs…
To identify devices/platforms in home-based patient management settings which can be developed…
To provide CI support through continuous monitoring and analysis of competitors’ developing footprints in PD-1/PD-L1 space across multiple indications.
To determine the switching behavior of patients and the magnitude of reasons for switching out.
C5i has been Certified as the Best Firm to Work for Data Scientists – 2026
C5i has been featured in the Gartner Market Guide for Digital Shelf Analytics
C5i has been recognized as a Strong Performer in The Forrester Wave™: Marketing Measurement and Optimization Services, Q1 2026
C5i has been recognized as a “Leader” in the Top Generative AI Service Providers 2026 by AIM Research
